Megan Prosser
Areas of Expertise
Immunotherapy, Cancer Biology, Genetics, and Molecular Biology
Featured Link
Dr. Megan Prosser is the Provost and Vice President of Academic Affairs at Keck Graduate Institute (KGI). Dr. Prosser has enjoyed an impactful career initially as a faculty member in the Azusa Pacific University Department of Biology and Chemistry, ultimately becoming the Department Chair and then Interim Dean of the College of Liberal Arts and Sciences. Dr. Prosser also served as Senior Advisor and Chief of Staff to the President of Azusa Pacific University.
During the last three years, Dr. Prosser has served on the KGI leadership team, initially as Dean of the Riggs School of Applied Life Sciences then becoming Vice President for Academic Affairs, Dean of the School of Health Sciences, and Dean of the School of Pharmacy. In addition to her role as Provost, Dr. Prosser continues to serve as the Dean of the School of Health Sciences.
As the chief academic office of KGI, Dr. Prosser leads the strategic vision for academic affairs, overseeing program expansion and development, academic effectiveness and faculty development, research, innovation, and strategic engagements, student affairs, career services, and student success initiatives.
She is active in developing and implementing innovative organizational structures and academic programming to further the KGI mission. Dr. Prosser is a committed leader/administrator and teacher/scholar who has made significant impacts on the education of STEM students who have gone on to successful careers in the health and biomedical sciences. She is particularly attuned to the mentoring of faculty coupled to academic program and curriculum development.
Dr. Prosser earned the B.S. degree in Biology and Chemistry with a Spanish Minor, Summa cum laude, from the University of Redlands. She earned the Ph.D. in Biological Sciences with an emphasis in Cancer Immunotherapeutics and Tumor Immunology from the Irell and Manella Graduate School of Biological Sciences at the City of Hope. Her research expertise focuses on adoptive immunotherapeutic approaches for enhanced cancer therapy.
- Prosser, M.E., Morris, J., and Clark, M. (Eds.) (2023) The Truth About Science: Answering Your Most Common Questions. Kendall Hunt.
- Hunter, M.R1.; Prosser, M.E1.; Mahadev, V.; Wang, X.; Aguilar, B.; Brown, C.E.; Forman, S.F.; Jensen, M.C. (2013) Homeostatic Engraftment of Human CD8+ Memory T Lymphocytes Expressing Autocrine Chimeric IL-7 Cytokine Receptors. Molecular Immunology 56(1-2): 1-11.
- Freeland, M.M.; Angulo J.; Davis A.L.; Flook A.M.; Garcia B.L.; King N.A.; Mangibin S.K.; Paul K.M.; Prosser, M.E.; Sata, N.; Bentley J.L.; Olson L.E. (2012) Sex differences in improved efficacy of doxorubicin chemotherapy in Cbr1+/- mice. Anticancer Drugs 23(6): 584-9.
- Prosser, M.E.; Brown, C.E.; Shami, A.F.; Jensen, M.C. (2011) Exploiting Tumor Expressed PD-L1 to Result in Costimulation Through the Expression of a PD1-CD28 Chimera in Primary Human CD8+ T Cells. Molecular Immunology 51(3-4): 263-72.
- Un, F.; Qi, C.; Prosser, M.; Wang, N.; Zhou, B.; Bronner, C.; Yen, Y. (2006) Modulating ICBP90 to Suppress Human Ribonucleotide Reductase M2 Induction Restores Sensitivity to Hydroxyurea Cytotoxicity. Anticancer Research 26(4B): 2761-7